These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24957790)

  • 1. A data-driven approach to modeling the tripartite structure of multidrug resistance efflux pumps.
    Phillips JL; Gnanakaran S
    Proteins; 2015 Jan; 83(1):46-65. PubMed ID: 24957790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of OprN and OprJ, outer membrane factors of multidrug tripartite efflux pumps of Pseudomonas aeruginosa.
    Yonehara R; Yamashita E; Nakagawa A
    Proteins; 2016 Jun; 84(6):759-69. PubMed ID: 26914226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.
    Andersen C
    Rev Physiol Biochem Pharmacol; 2003; 147():122-65. PubMed ID: 12783268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three's company: component structures bring a closer view of tripartite drug efflux pumps.
    Eswaran J; Koronakis E; Higgins MK; Hughes C; Koronakis V
    Curr Opin Struct Biol; 2004 Dec; 14(6):741-7. PubMed ID: 15582398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of a transmembrane drug-efflux pump from Gram-negative bacteria.
    Fernandez-Recio J; Walas F; Federici L; Venkatesh Pratap J; Bavro VN; Miguel RN; Mizuguchi K; Luisi B
    FEBS Lett; 2004 Dec; 578(1-2):5-9. PubMed ID: 15581607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
    Jamshidi S; Sutton JM; Rahman KM
    Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface.
    López CA; Travers T; Pos KM; Zgurskaya HI; Gnanakaran S
    Sci Rep; 2017 Nov; 7(1):16521. PubMed ID: 29184094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug transport mechanism of the AcrB efflux pump.
    Pos KM
    Biochim Biophys Acta; 2009 May; 1794(5):782-93. PubMed ID: 19166984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular architecture of the bacterial tripartite multidrug efflux pump focusing on the adaptor bridging model.
    Song S; Kim JS; Lee K; Ha NC
    J Microbiol; 2015 Jun; 53(6):355-64. PubMed ID: 26025167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update.
    Blair JM; Piddock LJ
    Curr Opin Microbiol; 2009 Oct; 12(5):512-9. PubMed ID: 19664953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transport activity of the fully assembled MexAB-OprM efflux pump from Pseudomonas aeruginosa.
    Verchère A; Dezi M; Adrien V; Broutin I; Picard M
    Nat Commun; 2015 Apr; 6():6890. PubMed ID: 25901994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant pH Molecular Dynamics Reveals How Proton Release Drives the Conformational Transition of a Transmembrane Efflux Pump.
    Yue Z; Chen W; Zgurskaya HI; Shen J
    J Chem Theory Comput; 2017 Dec; 13(12):6405-6414. PubMed ID: 29117682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and mechanism of bacterial tripartite efflux pumps.
    Neuberger A; Du D; Luisi BF
    Res Microbiol; 2018; 169(7-8):401-413. PubMed ID: 29787834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of efflux pumps in Gram-negative bacteria.
    Pagès JM; Masi M; Barbe J
    Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa.
    Sennhauser G; Bukowska MA; Briand C; Grütter MG
    J Mol Biol; 2009 May; 389(1):134-45. PubMed ID: 19361527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    Poole K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the adaptor (membrane fusion) protein hairpin domain for the functionality of multidrug efflux pumps.
    Stegmeier JF; Polleichtner G; Brandes N; Hotz C; Andersen C
    Biochemistry; 2006 Aug; 45(34):10303-12. PubMed ID: 16922505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the C-terminus of OprM is involved in the assembly of the VceAB-OprM efflux pump.
    Bai J; Mosley L; Fralick JA
    FEBS Lett; 2010 Apr; 584(8):1493-7. PubMed ID: 20206171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.